[go: up one dir, main page]

ES527994A0 - Un procedimiento para preparar derivados de piridina. - Google Patents

Un procedimiento para preparar derivados de piridina.

Info

Publication number
ES527994A0
ES527994A0 ES527994A ES527994A ES527994A0 ES 527994 A0 ES527994 A0 ES 527994A0 ES 527994 A ES527994 A ES 527994A ES 527994 A ES527994 A ES 527994A ES 527994 A0 ES527994 A0 ES 527994A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
piridine derivatives
piridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527994A
Other languages
English (en)
Other versions
ES8600245A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838322347A external-priority patent/GB8322347D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8600245A1 publication Critical patent/ES8600245A1/es
Publication of ES527994A0 publication Critical patent/ES527994A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES527994A 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de piridina. Granted ES527994A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8235590 1982-12-14
GB838322347A GB8322347D0 (en) 1983-08-19 1983-08-19 Pyridine derivatives

Publications (2)

Publication Number Publication Date
ES8600245A1 ES8600245A1 (es) 1985-10-01
ES527994A0 true ES527994A0 (es) 1985-10-01

Family

ID=26284681

Family Applications (3)

Application Number Title Priority Date Filing Date
ES527994A Granted ES527994A0 (es) 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de piridina.
ES543729A Expired ES8607241A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina
ES543728A Expired ES8605513A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES543729A Expired ES8607241A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina
ES543728A Expired ES8605513A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina

Country Status (8)

Country Link
US (2) US4532252A (es)
EP (1) EP0112142B1 (es)
AU (1) AU2222083A (es)
DE (1) DE3381674D1 (es)
DK (1) DK572583A (es)
ES (3) ES527994A0 (es)
GR (1) GR79163B (es)
PT (1) PT77808B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW7683A1 (en) * 1982-03-29 1984-01-04 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2 receptor antagonist activity
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
PT78358B (en) * 1983-04-07 1986-05-30 Smith Kline French Lab Chemical process
US4728648A (en) * 1985-02-09 1988-03-01 Smith Kline & French Laboratories Limited Histamine antagonist triadiazole derivatives, compositions, and method of use therefor
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
IE960442L (en) * 1988-12-27 1990-06-27 Takeda Chemical Industries Ltd Guanidine derivatives, their production and insecticides
CA2258536A1 (en) * 1996-06-17 1997-12-24 American Home Products Corporation Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
MXPA05003867A (es) * 2002-10-09 2005-11-23 Schering Corp Tiadiazoldioxidos y tiadiazoloxidos como ligandos de receptor cxc-y cc-quimiocina.
ES2308299T3 (es) * 2003-12-19 2008-12-01 Schering Corp Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas.
MXPA06007205A (es) * 2003-12-22 2006-08-31 Schering Corp Dioxidos de isotiazol como ligandos del receptor cxc y cc-quimiocina.
DE602004021404D1 (de) * 2004-12-23 2009-07-16 Gpc Biotech Ag Quadratsäurederivate mit antiproliferativer Wirkung
CN101253180B (zh) * 2005-06-29 2011-08-03 先灵公司 作为cxc-化学活素受体配体的5，6-二取代的*二唑吡嗪和噻二唑吡嗪
CA2613607A1 (en) * 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4120968A (en) * 1975-07-31 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic alkylaminocyclobutenediones
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4380639A (en) * 1981-03-03 1983-04-19 Bristol-Myers Company Substituted 1,2,5-thiadiazole derivatives
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4503051A (en) * 1981-05-18 1985-03-05 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
ZW7683A1 (en) * 1982-03-29 1984-01-04 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2 receptor antagonist activity
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
GB2131683B (en) * 1982-12-11 1986-03-12 Alma Ruby Skelcher Walking aid foot device
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
DE3374007D1 (en) * 1982-12-23 1987-11-12 Smith Kline French Lab Pyridine derivatives
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
ES8600245A1 (es) 1985-10-01
PT77808B (en) 1986-03-26
US4640926A (en) 1987-02-03
DK572583D0 (da) 1983-12-13
US4532252A (en) 1985-07-30
EP0112142A2 (en) 1984-06-27
ES543728A0 (es) 1986-03-16
DK572583A (da) 1984-06-15
ES8605513A1 (es) 1986-03-16
ES543729A0 (es) 1986-05-16
PT77808A (en) 1984-01-01
GR79163B (es) 1984-10-02
EP0112142A3 (en) 1986-01-15
EP0112142B1 (en) 1990-06-20
DE3381674D1 (de) 1990-07-26
ES8607241A1 (es) 1986-05-16
AU2222083A (en) 1984-06-21

Similar Documents

Publication Publication Date Title
ES543732A0 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES553614A0 (es) Un procedimiento para preparar derivados de alanil-prolina.
ES507620A0 (es) Un procedimiento para preparar un derivado de piridina .
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES528309A0 (es) Un procedimiento para preparar derivados de piridina
ES527994A0 (es) Un procedimiento para preparar derivados de piridina.
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES530392A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES512295A0 (es) Procedimiento para preparar derivados de piridina.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES557659A0 (es) Un procedimiento para preparar derivados de ciclopentil-eter.
ES555009A0 (es) Un procedimiento para preparar derivados de 3-hidroxibutanamido-acetato.
ES520709A0 (es) Un procedimiento para preparar derivados de piridina.
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES521955A0 (es) Un procedimiento para preparar derivados de cefalosporina.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES528310A0 (es) Un procedimiento para preparar derivados de piridina
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES536944A0 (es) Un procedimiento para preparar derivados de isoquinolinas.
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.